Kriegsmann, K., Bärtsch, M., Bruckner, T., Kriegsmann, M., Schmitt, A., Witzens-Harig, M., . . . Wuchter, P. (2017). Comparison of biosimilar filgrastim, originator filgrastim, and lenograstim for autologous stem cell mobilization in patients with multiple myeloma. Transfusion, 57(10), . https://doi.org/10.1111/trf.14211
Chicago Style (17th ed.) CitationKriegsmann, Katharina, Marc-Andrea Bärtsch, Thomas Bruckner, Mark Kriegsmann, Anita Schmitt, Mathias Witzens-Harig, Anthony Dick Ho, Jens Hillengaß, and Patrick Wuchter. "Comparison of Biosimilar Filgrastim, Originator Filgrastim, and Lenograstim for Autologous Stem Cell Mobilization in Patients with Multiple Myeloma." Transfusion 57, no. 10 (2017). https://doi.org/10.1111/trf.14211.
MLA (9th ed.) CitationKriegsmann, Katharina, et al. "Comparison of Biosimilar Filgrastim, Originator Filgrastim, and Lenograstim for Autologous Stem Cell Mobilization in Patients with Multiple Myeloma." Transfusion, vol. 57, no. 10, 2017, https://doi.org/10.1111/trf.14211.